The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Login
EN
+7 (495) 482-4118
+7 (495) 482-0604
+8 800 250-18-12
  • (toll-free number for subscriptions)
    Mon-Fri from 10 a.m. to 6 p.m.

  • © 1998-2025
+7 (495) 482-43-29
EN
All journals
Journal
Year
Year
Search result: 0

Ivanova P.I.

Scientific and Medical Laboratory «Aliquot» LLC;
I.I. Mechnikov Research Institute of Vaccines and Sera

Lobov A.V.

Scientific and Medical Laboratory «Aliquot» LLC;
I.I. Mechnikov Research Institute of Vaccines and Sera

Pogodina E.A.

Scientific and Medical Laboratory «Aliquot» LLC

Sorokina E.V.

I.I. Mechnikov Research Institute of Vaccines and Sera

Shubina I.Zh.

N.N. Blokhin National Medical Research Center of Oncology Ministry of Health of Russia

Laboratory tests for diagnostics of cell immunity against SARS-CoV-2 (review of literature)

Authors:

Ivanova P.I., Lobov A.V., Pogodina E.A., Sorokina E.V., Shubina I.Zh.

More about the authors

Journal: Laboratory Service. 2024;13(3): 31‑36

DOI: 10.17116/labs20241303131

Read: 827 times

Buy for 300₽
Contact the author
Table of contents

LABORATORY TESTS FOR DIAGNOSTICS OF CELL IMMUNITY AGAINST SARS-COV-2 (REVIEW OF LITERATURE)
LABORATORY TESTS FOR DIAGNOSTICS OF CELL IMMUNITY AGAINST SARS-COV-2 (REVIEW OF LITERATURE)

To cite this article:

Ivanova PI, Lobov AV, Pogodina EA, Sorokina EV, Shubina IZh. Laboratory tests for diagnostics of cell immunity against SARS-CoV-2 (review of literature). Laboratory Service. 2024;13(3):31‑36. (In Russ.)
https://doi.org/10.17116/labs20241303131

 
Подписка 2025 Лабораторная служба (Laboratory Service)
МСФ на ЯМ
Использование инфографики авторами научных работ
Recommended articles:
Deve­lopment and testing of the first dome­stic auto­matic cartridge-type POCT platform for the qualitative dete­rmination of SARS-CoV-2 RNA. Labo­ratory Service. 2024;(4):21-27
Comparative evaluation of gamma inte­rferen tests in vitro for dete­ction of cell-mediated immune response to reco­mbinant Myco­bacterium Tube­rculosis anti­gens in dete­ction of tube­rculosis infe­ction. Labo­ratory Service. 2025;(1):13-20
Dete­ction of mpox virus by enzyme immu­noassay in a no-instrumental format and after its inactivation with formaldehyde. Mole­cular Gene­tics, Microbiology and Viro­logy. 2024;(4):49-53
Post-Covid aortitis with cardiac invo­lvement: progressive aortic aneurysm combined with active myocarditis. Russian Journal of Archive of Pathology. 2025;(2):53-58
Therapeutic pote­ntial of quercetin and its deri­vatives against COVID-19. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(5):44-50
Inte­rcellular adhe­sion proteins: P-, E-, H-cadherins as onco­logical and cardiovascular diseases’ biomarkers. Russian Journal of Preventive Medi­cine. 2025;(7):100-105
Abstract:

To monitor the dynamics of the immune response against SARS-CoV-2, a test for the quantitative determination of IgG antibodies to the S protein of the SARS-CoV-2 coronavirus is used using chemiluminescent immunoassay (CLIA), which is standardized and widely implemented. There are no standardized methods for assessing and monitoring the cellular link of immunity against SARS-CoV-2, which is due to several reasons: the use of expensive equipment and reagents that are not included in the standard equipment of clinical diagnostic laboratories; lack of automated methods, high technological complexity of the study; underestimation of the role of T-cell immunity in providing long-term immune protection against SARS-CoV-2. Specific anti-SARS-CoV-2 T-cells circulate in the body for a longer time than the corresponding antibodies, so there is a need to monitor cellular immunity at the population level. Thus, reliable and scalable methods aimed at studying cellular immunity are needed. There are a number of tests that allow for fairly large-scale studies, such as ELISPOT (enzyme-linked immunosorbent assay), enzyme-linked immunosorbent assay (ELISA), and flow cytometry. Each method has its own advantages and disadvantages. There are active efforts to modernize, improve, and reduce the cost of various technologies and tests aimed at tracking the cellular link of immunity against SARS-CoV-2, with the goal of making them available for routine use.

Keywords:

SARS-CoV-2
cellular immunity
IGRA-tests
enzyme-linked immunosorbent assay
ELISPOT
T-cells

Authors:

Ivanova P.I.

Scientific and Medical Laboratory «Aliquot» LLC;
I.I. Mechnikov Research Institute of Vaccines and Sera

Lobov A.V.

Scientific and Medical Laboratory «Aliquot» LLC;
I.I. Mechnikov Research Institute of Vaccines and Sera

Pogodina E.A.

Scientific and Medical Laboratory «Aliquot» LLC

Sorokina E.V.

I.I. Mechnikov Research Institute of Vaccines and Sera

Shubina I.Zh.

N.N. Blokhin National Medical Research Center of Oncology Ministry of Health of Russia

Received:

25.07.2024

Accepted:

07.11.2024

Close metadata

References:

  1. Sekine T, Perez-Potti A, Rivera-Ballesteros O, et al. Robust T Cell Immunity in Convalescent Individuals with Asymptomatic or Mild COVID-19. Cell. 2020;183(1):158-168.  https://doi.org/10.1016/j.cell.2020.08.017
  2. Rijkers G, Murk J, Wintermans B, et al. Differences in Antibody Kinetics and Functionality Between Severe and Mild Severe Acute Respiratory Syndrome Coronavirus 2 Infections. The Journal of Infectious Diseases. 2020;222(8):1265-1269. https://doi.org/10.1093/infdis/jiaa463
  3. Feng C, Shi J, Fan Q, et al. Protective humoral and cellular immune responses to SARS-CoV-2 persist up to 1 year after recovery. Nat Commun. 2021;12(1):4984. https://doi.org/10.1038/s41467-021-25312-0
  4. Dan JM, Lindestam Arlehamn CS, Weiskopf D, et al. A cytokine-independent approach to identify antigen-specific human germinal center T follicular helper cells and rare antigen-specific CD4 T cells in blood. J Immunol. 2016;197:983-993.  https://doi.org/10.4049/jimmunol.1600318
  5. Kedzierska K, Thomas PG. Count on us: T cells in SARS-CoV-2 infection and vaccination. Cell Rep. 2022;3(3):100562. https://doi.org/10.1016/j.xcrm.2022.100562
  6. Toptygina A.P., Semikina E.L., Zakirov R.Sh., Afridonova Z.E. Comparison of the humoral and cellular immunity in COVID-19 convalescents. Russian Journal of Infection and Immunity=Infektsiya i immunitet. 2022;12(3):495-504. (In Russ.). https://doi.org/10.15789/2220-7619-COT-1809
  7. Bertoletti A, Tan A, Le Bert N. The T cell response to SARS-CoV-2: kinetic and quantitative aspects and the case for their protective role. Oxford Open Immunol. 2021;2(1):iqab006. https://doi.org/10.1093/oxfimm/iqab006
  8. Bonifacius A, Tischer-Zimmermann S, Dragon AC, et al. COVID-19 immune signatures reveal stable antiviral T cell function despite declining humoral responses. Immunity. 2021;54:340-354.  https://doi.org/10.1016/J.immuni.2021.01.008
  9. Jung JH, Rha MS, Sa M, et al. SARS-CoV-2-specific T cell memory is sustained in COVID-19 convalescent patients for 10 months with successful development of stem cell-like memory T cells. Nat Commun. 2021;12:4043. https://doi.org/10.1038/s41467-021-24377-1
  10. Le Bert N, Clapham HE, Tan AT, et al. Highly Functional Virus-Specific Cellular Immune Response in Asymptomatic SARS-CoV-2 Infection. J Exp Med. 2021;218(5):e20202617. https://doi.org/10.1084/jem.20202617
  11. Czerkinsky CC, Nilsson LA, Nygren H, et al. Solid-phase enzyme-linked immunospot (ELISPOT) assay for enumeration of specific antibody-secreting cells. J Immunol Methods. 1983;65(1-2):109-121.  https://doi.org/10.1016/0022-1759(83)90308-3
  12. Cox J, Ferrari G, Janetzki S. Measurement of Cytokine Release at the Single Cell Level Using the ELISPOT Assay. Methods. 2006;38:274-282.  https://doi.org/10.1016/j.ymeth.2005.11.006
  13. Gazagne A, Claret E, Wijdenes J, et al. A Fluorospot Assay to Detect Single T Lymphocytes Simultaneously Producing Multiple Cytokines. J Immunol Methods. 2003;283(1-2):91-98.  https://doi.org/10.1016/j.jim.2003.08.013
  14. Tukhvatulin AI, Dolzhikova IV, Shcheblyakov DV, et al. An Open, non-Randomised, Phase 1/2 Trial on the Safety, Tolerability, and Immunogenicity of Single-Dose Vaccine «Sputnik Light» for Prevention of Coronavirus Infection in Healthy Adults. Lancet Regional Health Europe. 2021;11:100241. https://doi.org/10.1016/j.lanepe.2021.100241
  15. Lehmann PV, Zhang W. Unique strengths of ELISPOT for T cell diagnostics. Methods Mol Biol. 2012;792:3-23. 
  16. Kruse M, Dark C, Aspden M, et al. Performance of the T-SPOT.COVID test for detecting SARS-CoV-2-responsive T cells. Int J Infect Dis. 2021;113:155-161.  https://doi.org/10.1016/j.ijid.2021.09.073
  17. Poteryaev DA, Abbasova SG, Ignatyeva PE, Strizhakova OM, Kolesnik SV, Khamitov RA. Assessment of T-cell immunity to SARS-CoV-2 in COVID-19 convalescents and vaccinated subjects, using TigraTest® SARS-CoV-2 ELISPOT kit. BIOpreparaty. Profilaktika, diagnostika, lechenie=BIOpreparations. Prevention, Diagnosis, Treatment. 2021;21(3):178-192. (In Russ.). https://doi.org/10.30895/2221-996X-2021-21-3-178-192
  18. Mallone R, Mannering SI, Brooks-Worrell BM, Durinovic-Bello I, Cilio CM, Wong FS, Schloot NC. Isolation and preservation of peripheral blood mononuclear cells for analysis of islet antigen-reactive T cell responses: position statement of the T-Cell Workshop Committee of the Immunology of Diabetes Society. Clinical & Experimental Immunology. 2011;163(1):33-49.  https://doi.org/10.1111/j.1365-2249.2010.04272.x
  19. Lamara Mahammed L, Bensaid K, Ait-Seddik S, et al. Improved Performance of the QuantiFERON-SARS-CoV-2 Assay with the Extended Set. Viruses. 2023;15(5):1179. https://doi.org/10.3390/v15051179
  20. QuantiFERON SARS-CoV-2. accessed 5 July 2023. QuantiFERON SARS-CoV-2 RUO (qiagen.com).
  21. Bowyer G, Rampling T, Powlson J, et al. Activation-Induce Markers Detect Vaccine-Specific CD4+ T Cell Responses Not Measured by Assays Conventionally Used in Clinical Trials. Vaccines. 202;6(3):1347-1348. https://doi.org/10.3390/vaccines6030050
  22. Dan JM, Lindestam Arlehamn CS, Weiskopf D, et al. A Cytokine-Independent Approach To Identify Antigen-Specific Human Germinal Center T Follicular Helper Cells and Rare Antigen-Specific CD4+ T Cells in Blood. J Immunol. 2016;197:983-993.  https://doi.org/10.4049/jimmunol.1600318
  23. Schwarz M, Mzoughi S, Lozano-Ojalvo D, et al. T Cell Immunity Is Key to the Pandemic Endgame: How to Measure and Monitor It. Curr Res Immunol. 2022;3:215-221.  https://doi.org/10.1016/j.crimmu.2022.08.004
  24. Tada T, Zhou H, Samanovic MI, et al. Comparison of neutralizing antibody titers elicited by mRNA and adenoviral vector vaccine against SARS-CoV-2 variants. bioRxiv, preprint.
  25. Barouch DH, Stephenson KE, Sadoff J, et al. Durable humoral and cellular immune responses 8 months after Ad26.COV2.S vaccination. N Engl J Med. 2021;385:951-953.  https://doi.org/10.1056/NEJMc2108829
  26. Lin H, Zhang J, Dong S, et al. An adjusted ELISpot-based immunoassay for evaluation of SARS-CoV-2-specific T-cell responses. Biosaf Health. 2022;4(3):179-185.  https://doi.org/10.1016/j.bsheal.2022.04.005
  27. Mak, W.A., Koeleman, J.G.M., Ong, D.S.Y. Development of an In-House SARS-CoV-2 Interferon-Gamma ELISpot and Plate Reader-Free Spot Detection Method. J. Virol. Methods. 2022;300:114398. https://doi.org/10.1016/j.jviromet.2021.114398
  28. Villemonteix J, Cohen L, Guihot A, et al. Comparison between Enzyme-linked Immunospot Assay and Intracellular Cytokine Flow Cytometry Assays for the Evaluation of T Cell Response to SARS-CoV-2 after Symptomatic COVID-19. Immun. Inflamm. Dis. 2022;10:e617. https://doi.org/10.1002/iid3.617
  29. Bergami F., Arena F., Pattonieri E. F. et al. Performance of whole blood stimulation assays for the quantification of SARS-CoV-2 specific T-cell response: A cross-sectional study. Diagnostics. 2022;12(6):1509. https://doi.org/10.3390/diagnostics12061509
  30. Aiello A, Coppola A, Vanini V, et al. Accuracy of QuantiFERON SARS-CoV-2 research use only assay and characterization of the CD4+ and CD8+ T cell-SARS-CoV-2 response: comparison with a homemade interferon-γ release assay. International Journal of Infectious Diseases. 2022;122:841-849.  https://doi.org/10.1016/j.ijid.2022.07.049
  31. Krüttgen A, Klingel H, Haase G, et al. Evaluation of the QuantiFERON SARS-CoV-2 Interferon-ɣ Release Assay in MRNA-1273 Vaccinated Health Care Workers. J. Virol. Methods. 2021;298:114295. https://doi.org/10.1016/j.jviromet.2021.114295
  32. Ning B, Chandra S, Rosen J, et al. Evaluation of SARS-CoV-2-Specific T-Cell Activation with a Rapid On-Chip IGRA. ACS Nano. 2023;17(2):1206-1216. https://doi.org/10.1021/acsnano.2c09018
Contact the author
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

Contact us
If you have any questions, complaints or suggestions, please use this feedback form.
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.
Submit Application

You can become an author of one of our magazines, send a request and we will consider it in during the day.

Name
Phone
E-mail
Message
Login
Registration
E-mail
Password
Forgot Password?

Log in to the site using your account in one of the services

Password recovery
E-mail
Login
Register

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.